Tumor bed boost omission after negative re-excision in breast-conservation treatment

Annals of Surgical Oncology

Volumn 13, Issue 6, 2006, Pages 794-801

  Arthur, Douglas W ^a   Cuttino, Laurie W ^a   Neuschatz, Andrew C ^b,c   Koo, Derrick T ^a   Morris, Monica M ^a   Bear, Harry D ^d   Kaplan, Brian J ^d   Dawson, Kathy ^d   Wazer, David E ^b,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Breast conservation therapy; Lumpectomy; Radiation boost; Radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CELL INFILTRATION; CONSERVATIVE TREATMENT; EARLY CANCER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; OPERATION DURATION; PARTIAL MASTECTOMY; RADIATION DOSE; RECURRENCE RISK; RISK REDUCTION; TUMOR BED BOOST; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT;

EID: 33646563460     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/ASO.2006.04.002     Document Type: Article

References (31)

1. Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 2001; 12:997-1003.
2. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of randomized study comparing breast-conserving surgery with radical (Halstead) mastectomy for early breast cancer. N Engl J Mad 2002; 347:1227-32.
3. Clark RM, McCulloch PB, Levine MN, et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 1992; 84:683-9.
4. Uppsala-Oreboro Breast Cancer Study Group. Sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Natl Cancer Inst 1990; 82:277-82.
5. Recht A, Silver B, Schnitt S, et al. Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys 1985; 11:1271-6.
6. Smith TE, Daesung L, Turner BC, et al. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 2000; 48:1281-9.
7. Obedian E, Fischer DB, Haffty BG. Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy. J Clin Oncol 2000; 18:2406-12.
8. Fisher B, Anderson S. Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. World J Surg 1994; 18:63-9.
9. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of protocol B-17. Cancer 1999; 86:429-38.
10. Holli K, Saaristo R, Isola J, et al. Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study. Br J Cancer 2001; 84:164-9.
11. Morrow M. Rational local therapy for breast cancer. N Engl J Med 2002; 347:1270-1.
12. Hayman JA, Hillner BE, Harris JR, et al. Cost-effectiveness of adding an electron-beam boost to tangential radiation therapy in patients with negative margins after conservative surgery for early-stage breast cancer. J Clin Oncol 2000; 18:287-95.
13. Romestaing P, Lehinge Y, Carrie C, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 1997; 15:963-8.
14. Polgar C, Fodor J, Orosz Z, et al. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer: first results of the randomized Budapest boost trial. Strahlenther Onkol 2002; 178:615-23.
15. Bartelink H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001; 345:1378-87.
16. Schmidt-Ullrich RK, Wazer DE, Tercilla O, et al. Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early stage breast carcinoma. Int J Radiat Oncol Biol Phys 1989; 17:733-8.
17. Wazer DE, Sinesi M, Schmidt-Ullrich RK, et al. Importance of surgical and pathologic determinants of tumor margin status for breast conservation therapy. Breast Dis 1991; 4:285-92.
18. Schmidt-Ullrich RK, Wazer DE, DiPetrillo T, et al. Breast conservation therapy for early stage breast carcinoma with outstanding 10-year locoregional control rates: a case for aggressive therapy to the tumor bearing quadrant. Int J Radiat Oncol Biol Phys 1993; 27:545-52.
19. Wazer DE, Schmidt-Ullrich RK, Schmid CH, et al. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden. Int J Radiat Oncol Biol Phys 1997; 38:291-9.
20. Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al. Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys 1998; 40:851-8.
21. Neuschatz AC, DiPetrillo T, Safaii H, et al. Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy. Cancer 2003; 97:30-9.
22. Marubini E, Valsecchi M. Analysing Survival Data From Clinical Trials and Observational Studies. Chichester: Wiley, 1995.
23. Recht A, Harris JR. To boost or not to boost, and how to do it. Int J Radiat Oncol Biol Phys 1991; 20:177-8.
24. Pezner RD. Cosmetic breast fibrosis: it's the local boost!. Int J Radiat Oncol Biol Phys 1994; 30:1251-2.
25. Regine WF, Kramer CA. To boost or not to boost?...it's not the only question! In response to Pezner. Int J Radiat Oncol Biol Phys 30:1251-2; 1994. Int J Radiat Oncol Biol Phys 1995; 32:273-7.
26. Fischer B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347:1233-41.
27. Fischer B, Bower M, Margolese R, et al. Five year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985; 312:665-73.
28. Vrieling C, Collette L, Fourquet A, et al. The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. Int J Radiat Oncol Biol Phys 1999; 45:677-85.
29. Vrieling C, Collette L, Fourquet A, et al. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC "boost vs no boost" trial. Radiother Oncol 2000; 55:219-32.
30. Pezner RD, Wagman LD, Ben-Ezra J, et al. Breast conservation therapy: local tumor control in patients with pathologically clear margins who receive 5000cGy breast irradiation without local boost. Breast Cancer Res Treat 1994; 32:261-7.
31. Gelman R, Gelber R, Henderson IC, et al. Improving methodology for analyzing local and distant recurrence. J Clin Oncol 1990; 8:548-55.